Table 2 Laboratory findings of patients with COVID-19.

From: Moderate vs. mild cases of overseas-imported COVID-19 in Beijing: a retrospective cohort study

Laboratory findings

Reference range

Mild (n = 21)

Moderate (n = 32)

p

Blood cell count

White blood cell count, × 109/L

3.5–9.5

5.1[4.05–5.2]

5.2[3.82–6.25]

0.894a

Neutrophil count, × 109/L

1.8–6.3

2.11[1.69–3.23]

3.12[1.88–4.33]

0.068a

Neutrophil percentage, %

40–75

43.9[37.8–54.2]

57.3[48.25–64.7]

 < 0.001a

Lymphocyte count, × 109/L

1.1–3.2

2.25[1.62–2.85]

1.65[1.21–2.10]

0.010a

Lymphocyte percentage, %

20–50

44.0[35.8–50.05]

33.5[28.7–41.3]

0.003a

NLR

Ā 

0.96[0.72–1.47]

1.74[1.19–2.18]

 < 0.001a

Haemoglobin, g/L

130–175

134[127.5–141.5]

142.0[123.5–148.5]

0.467a

Platelet count, × 109/L

125–350

210[191.5–247.0]

195.0[171.0–268]

0.743a

Blood biochemistry

Albumin, g/L

40–50

44.4[43.25–46.55]

43.15[41.52–44.97]

0.072a

ALT, U/L

9–50

14.2[10.5–20.45]

18.1[6.51–12.75]

0.029a

AST, U/L

15–40

18.6[15.5–20.85]

20.5[17.2–24.85]

0.256a

Total bilirubin, mmol/L

1.7–23

10.13[6.84–12.28]

8.88[6.56–12.75]

0.611a

Potassium, mmol/L

3.5–5.3

4.20[4.12–4.72]

4.47[4.13–4.95]

0.317a

Sodium, mmol/L

137–147

139.6[138.25–141.55]

139.45[137.92–141.45]

0.849a

Creatinine, μmol/L

57–97

59.2[54.15–66.45]

67.7[58.67–91.27]

0.033a

LDH, U/L

120–250

163.30[143.25–199.15]

181.05[149.85–212.00]

0.252a

cTnI, pg/mL

0–40

0.1[0.1–0.1]

0.1[0.1–0.1]

0.418a

CKMB, U/L

0–25

8.8[8.0–12.1]

10.3[8.125–14.475]

0.287a

Triglyceride, mmol/L

0.6–1.7

0.68[0.54–1.01]

0.88[0.776–1.02]

0.052a

HDL, mmol/L

1.04–1.56

2.19[1.73–2.83]

1.45[1.13–2.42]

0.008a

LDL, mmol/L

1.03–3.38

2.21[1.65–2.42]

2.19[1.73–2.83]

0.335a

Total cholesterol, mmol/L

3.1–5.2

3.94[3.45–4.42]

3.80[3.25–4.61]

0.920a

Glucose, mmol/L

3.9–6.1

4.93[4.57–5.10]

4.92[4.72–5.19]

0.518a

Lactic acid, mmol/L

0–2

2.1[1.8–2.3]

2.1[1.7–2.4]

0.802a

Coagulation

PT, s

9.1–12.1

13.6[13.35–14.15]

13.6[13.12–14.00]

0.964a

APTT, s

25.4–38.4

39.8[35.5–42.55]

39.15[37.00–45.22]

0.418a

Fibrinogen, mg/dL

2–4

2.62[2.495–3.015]

3.48[2.88–3.87]

 < 0.001a

D-dimer, mg/L

0–231

220[220–300]

270[220–402.5]

0.127a

Infection-related

PCT, ng/mL

0.02–0.5

0.03[0.03–0.375]

0.04[0.03–0.067]

0.007a

CRP, mg/L

0–6

0.39[0.165–1.335]

3.41[0.865–17.24]

0.010a

ESR, mm/h

0–15

7.0[4.0–10.5]

14.0[7.25–24.5]

0.001a

Radiologic findings

GGO

Ā Ā 

28(87.5)

Ā 

Consolidation

Ā Ā 

14(43.8)

Ā 

Lesion distribution

Ā Local

Ā Ā 

17(53.1)

Ā 

Ā Multifocal

Ā Ā 

15(46.9)

Ā 

Ā Unilateral

Ā Ā 

22(68.8)

Ā 

Ā Bilateral

Ā Ā 

10(31.3)

Ā 

Total CT score

Ā Ā 

2[1–3]

Ā 
  1. Laboratory findings are presented as the median (25% quantile-75% quantile); radiologic findings are presented as the number of cases (percentage).
  2. NLR neutrophil-to-lymphocyte ratio; ALT alanine aminotransferase; AST aspartate aminotransferase; LDH lactate dehydrogenase; cTnI cardiac troponin I; CKMB MB isoenzyme of creatine kinase; HDL high density lipoprotein; LDL low density lipoprotein; PT prothrombin time; APTT activated partial thromboplastin time; PCT procalcitonin; CRP C-reactive protein; ESR erythrocyte sedimentation rate; GGO ground glass opacity.
  3. ap according to the Wilcoxon rank sum test.
  4. All bold values indicate significant differences at the level of 0.05 for a highlight purpose.